Mediators of Inflammation

/ Table of Contents: 1995

Table of Contents

Table of Contents: 1995

Mediators of Inflammation -
Special Issue
Volume 4
- Article ID 803523

Defective antigen presentation by monocytes in ESRD patients not responding to hepatitis B vaccination: impaired HBsAg internalization and expression of ICAM-1 and HLA-DR/Ia molecules

J. Stachowski | C. Barth | ... | C. A. Baldamis

Mediators of Inflammation -
Special Issue
- Volume 4
- Article ID 709586

Treatment of allergic rhinoconjunctivitis: a review of the role of topical levocabastine

R. Gerth van Wijk

Mediators of Inflammation -
Special Issue
- Volume 4
- Article ID 654634

A review of the tolerability and safety of levocabastine eye drops and nasal spray. Implications for patient management

Peter H. Howarth

Mediators of Inflammation -
Special Issue
- Volume 4
- Article ID 148986

Topical levocabastine—a review of therapeutic efficacy compared with topical sodium cromoglycate and oral terfenadine on days with high pollen counts

Marianela de Azevedo

Mediators of Inflammation -
Special Issue
Volume 4
- Article ID 201279

Role of lysosomal enzymes released by alveolar macrophages in the pathogenesis of the acute phase of hypersensitivity pneumonitis

J. L. Pérez-Arellano | M. N. Barrios | ... | A. Jiménez

Mediators of Inflammation -
Special Issue
- Volume 4
- Article ID 795712

Levocabastine eye drops are effective and well tolerated for the treatment of allergic conjunctivitis in children

Brunello Wüthrich | Martin Gerber

Mediators of Inflammation -
Special Issue
- Volume 4
- Article ID 582151

Efficacy and tolerability of levocabastine and azelastine nasal sprays for the treatment of allergic rhinitis

Ralph Mösges | Joachim Spaeth | Ludger Klimek

Mediators of Inflammation -
Special Issue
- Volume 4
- Article ID 924194

Faster onset of action with topical levocabastine than with oral cetirizine

Michel A. Drouin | William H. Yang | Frederick Horak

Mediators of Inflammation -
Special Issue
- Volume 4
- Article ID 207175

Introduction

Paul Van Cauwenberge

Mediators of Inflammation -
Special Issue
Volume 4
- Article ID 528646

Book review

Johan C. de Jongste

Mediators of Inflammation -
Special Issue
Volume 4
- Article ID 408269

Tumour necrosis factor-α and adenosine in endotoxin shockleading related cardiovascular symptoms

S. Sipka | T. Seres | ... | G. Szegedi

Mediators of Inflammation -
Special Issue
Volume 4
- Article ID 878946

Clostridium difficile suppresses colonic vasoactive intestinal peptide associated with altered motility

A. Nassif | W. E. Longo | ... | D. L. Kaminski

Mediators of Inflammation -
Special Issue
Volume 4
- Article ID 718741

Abrogation of mercuric chloride-induced nephritis in the Brown Norway rat by treatment with antibodies against TNFα

A. Molina | F. Sánchez-Madrid | ... | F. Mampaso

Mediators of Inflammation -
Special Issue
Volume 4
- Article ID 973735

Cytotoxicity towards human endothelial cells, induced by neutrophil myeloperoxidase: protection by ceftazidime

M. Mathy-Hartert | G. Deby-Dupont | ... | M. Lamy

Mediators of Inflammation -
Special Issue
Volume 4
- Article ID 949643

Elevation of soluble interleukin-2 receptor levels in nasal allergy

K. Hisamatsu | T. Ganbo | ... | Y. Murakami

Evaluate your manuscript with the free Manuscript Language Checker

Author guidelines

Editorial board

Databases and indexing

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.